2021-06-17 |
1 |
Complaint |
expiration of U.S. Patent Nos. 8,324,225 (“the ’225 patent”), 8,415,355 (“the ’355 patent”),
…’225 patent, the ’355 patent, the ’980 patent, the ’630 patent, the ’732 patent, the ’136
patent, the…’225 patent, the ’355
patent, the ’980 patent, the ’630 patent, the ’732 patent, the ’136 patent, the…’225 patent, the ’355 patent, the ’980 patent, the ’630 patent, the ’732 patent, the ’136
patent, the…’225 patent, the ’355 patent,
the ’980 patent, the ’630 patent, the ’732 patent, the ’136 patent, the |
External link to document |
2021-06-17 |
4 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,324,225 ;8,415,355 ;8,685,980… 17 June 2021
1:21-cv-00870
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2021-06-17 |
5 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,416,136 ;9,868,739 ;10,799,… 17 June 2021
1:21-cv-00870
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |